Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs.
about
Translating RNA sequencing into clinical diagnostics: opportunities and challenges.Crucial considerations for pipelines to validate circulating biomarkers for breast cancer.Amplification-free detection of microRNAs via a rapid microarray-based sandwich assay.Can nanotechnology improve cancer diagnosis through miRNA detection?
P2860
Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cross Platform Standardisation ...... ated Human Circulating MiRNAs.
@ast
Cross Platform Standardisation ...... ated Human Circulating MiRNAs.
@en
type
label
Cross Platform Standardisation ...... ated Human Circulating MiRNAs.
@ast
Cross Platform Standardisation ...... ated Human Circulating MiRNAs.
@en
prefLabel
Cross Platform Standardisation ...... ated Human Circulating MiRNAs.
@ast
Cross Platform Standardisation ...... ated Human Circulating MiRNAs.
@en
P2093
P2860
P50
P1433
P1476
Cross Platform Standardisation ...... ated Human Circulating MiRNAs.
@en
P2093
Eoin Clancy
Helena Kelly
Nina L Tuite
Thomas Barry
Tim Downing
P2860
P304
P356
10.1371/JOURNAL.PONE.0137389
P407
P577
2015-09-10T00:00:00Z